Physician profile
John G Lockie
NPI 1124076450
$1,144.04
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $111 · 2021: $16.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $226.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $199.60 | 2019-2020 | |
| Amgen INC. | $146.81 | 2019 | |
| Pfizer INC. | $140.58 | 2019-2020 | |
| Astellas Pharma US INC | $72.23 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.97 | 2019 | |
| Lilly USA, LLC | $46.12 | 2019-2020 | |
| Allergan, INC. | $37.77 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.04 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.41 | 2019 | |
| Si-Bone, INC. | $23.13 | 2019 | |
| Glaxosmithkline, LLC. | $21.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.99 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.58 | 2021 | |
| Sanofi Pasteur INC. | $13.95 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lockie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.